MYX 0.00% $3.88 mayne pharma group limited

Ann: Non-Executive Director appointment and retirement, page-12

  1. 3,910 Posts.
    lightbulb Created with Sketch. 2765
    Mostly agree and you may be right with the logic. Alas, logic has often not been applied to this business from within, which naturally makes new investors here reticent and the market more sceptical. I think once there is cold, hard evidence that Mayne has actually turned the corner, including the appointment and bedding in of a credible US-based CEO, we might get to see some market confidence restored. The new CEO’s first major communication with the market/shareholders may well do this imo - i.e. a comprehensive laying out of the new business strategy and direction under his/her helm.

    Evidence of M&A action likewise will improve things here quite rapidly, but that is just talk at the moment and I think there’s still a bit of water to go under the bridge first, such is the low level of faith & confidence that this stock has (deservedly) earned itself after years of managerial madness! We are also quite exposed as a business to the US economic picture/outlook/direction so that will definitely remain a factor in play too, I think.

    What would be very nice is for us all to feel naturally inclined by default towards optimism when looking at this ticker - that day hopefully draws near!
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$3.88
Change
0.000(0.00%)
Mkt cap ! $330.0M
Open High Low Value Volume
$3.89 $3.94 $3.87 $178.6K 45.81K

Buyers (Bids)

No. Vol. Price($)
1 587 $3.88
 

Sellers (Offers)

Price($) Vol. No.
$3.90 137 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.